Moreover, we observed that inhibiting NAT10 with Remodelin or shRNA resulted in a significant reduction in hypoxic areas and cell necrosis within tumors (Figure 1C, D and Figure S1D, E), and tumor volumes and weights were effectively reduced compared to their respective negative controls (Figure 1E, F). Here, NAT10 is linked to neoplasm.